Cargando…
Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
Vancomycin-resistant enterococcus (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population...
Autores principales: | Benamu, Esther, Deresinski, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750719/ https://www.ncbi.nlm.nih.gov/pubmed/29333263 http://dx.doi.org/10.12688/f1000research.11831.1 |
Ejemplares similares
-
Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient
por: Bashir, Ali, et al.
Publicado: (2017) -
Epidemiology of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Colonization in Nursing Facilities
por: Davis, Elyse, et al.
Publicado: (2020) -
The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients
por: Yemişen, Mücahit, et al.
Publicado: (2016) -
213. Prophylactic oral vancomycin for Clostridioides difficile in allogeneic hematopoietic stem cell transplant recipients
por: Ogawa, Lauren, et al.
Publicado: (2022) -
Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient
por: Eden, Gabriele, et al.
Publicado: (2012)